Benzinga | Nov 3, 2021 05:05PM EDT

10x Genomics Q3 EPS $(0.15) Beats $(0.20) Estimate, Sales $125.30M Beat $122.62M Estimate

10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.20) by 25 percent. This is a 76.92 percent increase over losses of $(0.65) per share from the same period last year. The company reported quarterly sales of $125.30 million which beat the analyst consensus estimate of $122.62 million by 2.18 percent. This is a 74.47 percent increase over sales of $71.82 million the same period last year.